Virus de la fièvre jaune : Questions médicales fréquentes
Nom anglais: Yellow fever virus
Descriptor UI:D015005
Tree Number:B04.820.578.344.350.990
Termes MeSH sélectionnés :
Facilities and Services Utilization
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus de la fièvre jaune : Questions médicales les plus fréquentes",
"headline": "Virus de la fièvre jaune : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus de la fièvre jaune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-17",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus de la fièvre jaune"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Flavivirus",
"url": "https://questionsmedicales.fr/mesh/D005416",
"about": {
"@type": "MedicalCondition",
"name": "Flavivirus",
"code": {
"@type": "MedicalCode",
"code": "D005416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.578.344.350"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus de la fièvre jaune",
"alternateName": "Yellow fever virus",
"code": {
"@type": "MedicalCode",
"code": "D015005",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Betânia Paiva Drumond",
"url": "https://questionsmedicales.fr/author/Bet%C3%A2nia%20Paiva%20Drumond",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Marta Giovanetti",
"url": "https://questionsmedicales.fr/author/Marta%20Giovanetti",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Flavivírus, Instituto Oswaldo Cruz Fiocruz, Rio de Janeiro, Brazil giovanetti.marta@gmail.com."
}
},
{
"@type": "Person",
"name": "Pedro Augusto Alves",
"url": "https://questionsmedicales.fr/author/Pedro%20Augusto%20Alves",
"affiliation": {
"@type": "Organization",
"name": "Instituto René Rachou/Fundação Oswaldo Cruz, 30190-002 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Matheus Soares Arruda",
"url": "https://questionsmedicales.fr/author/Matheus%20Soares%20Arruda",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Gabriela Fernanda Garcia Oliveira",
"url": "https://questionsmedicales.fr/author/Gabriela%20Fernanda%20Garcia%20Oliveira",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Charge midwives' awareness of and their role in promoting respectful maternity care at a tertiary health facility in Ghana: A qualitative study.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37186643",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0284326"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of an Outbreak Cluster of Extensively Antibiotic-Resistant GC1 Acinetobacter baumannii Isolates in U.S. Military Treatment Facilities.",
"datePublished": "2023-05-04",
"url": "https://questionsmedicales.fr/article/37140387",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.00462-23"
}
},
{
"@type": "ScholarlyArticle",
"name": "Facile synthesis of core-shell Co-MOF with hierarchical porosity for enhanced electrochemical detection of furaltadone in aquaculture water.",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37225339",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aca.2023.341296"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis.",
"datePublished": "2023-04-24",
"url": "https://questionsmedicales.fr/article/37093241",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00277-023-05194-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Midwives' perceptions towards the ministry of health guidelines for the provision of immediate postpartum care in rural health facilities in Uganda.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37072738",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05585-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN à brin positif",
"item": "https://questionsmedicales.fr/mesh/D000085102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Flaviviridae",
"item": "https://questionsmedicales.fr/mesh/D018067"
},
{
"@type": "ListItem",
"position": 6,
"name": "Flavivirus",
"item": "https://questionsmedicales.fr/mesh/D005416"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus de la fièvre jaune",
"item": "https://questionsmedicales.fr/mesh/D015005"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus de la fièvre jaune - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus de la fièvre jaune",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus de la fièvre jaune",
"description": "Comment diagnostique-t-on la fièvre jaune ?\nQuels tests sont utilisés pour la fièvre jaune ?\nQuand faire un test pour la fièvre jaune ?\nPeut-on confondre la fièvre jaune avec d'autres maladies ?\nQuels sont les symptômes initiaux de la fièvre jaune ?",
"url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus de la fièvre jaune",
"description": "Quels sont les symptômes de la fièvre jaune ?\nLa fièvre jaune cause-t-elle des saignements ?\nQuels signes indiquent une forme sévère ?\nCombien de temps durent les symptômes ?\nY a-t-il des symptômes spécifiques chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus de la fièvre jaune",
"description": "Comment prévenir la fièvre jaune ?\nQui doit se faire vacciner contre la fièvre jaune ?\nQuels sont les effets secondaires du vaccin ?\nComment éviter les piqûres de moustiques ?\nLe vaccin est-il efficace immédiatement ?",
"url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus de la fièvre jaune",
"description": "Quel est le traitement de la fièvre jaune ?\nComment gérer la déshydratation due à la fièvre jaune ?\nDes médicaments peuvent-ils aider ?\nLa transfusion sanguine est-elle nécessaire ?\nPeut-on utiliser des antibiotiques pour la fièvre jaune ?",
"url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus de la fièvre jaune",
"description": "Quelles sont les complications possibles de la fièvre jaune ?\nLa fièvre jaune peut-elle être mortelle ?\nQuels facteurs augmentent le risque de complications ?\nComment se manifeste l'insuffisance hépatique ?\nY a-t-il des séquelles après la fièvre jaune ?",
"url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus de la fièvre jaune",
"description": "Qui est le plus à risque de contracter la fièvre jaune ?\nLes voyageurs doivent-ils se préoccuper de la fièvre jaune ?\nLes personnes non vaccinées sont-elles plus vulnérables ?\nLes enfants sont-ils plus à risque ?\nLes personnes âgées sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D015005?mesh_terms=Facilities+and+Services+Utilization&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la fièvre jaune ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la fièvre jaune ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques IgM et IgG ainsi que la PCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quand faire un test pour la fièvre jaune ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests doivent être effectués dès l'apparition des symptômes, généralement dans les 7 jours."
}
},
{
"@type": "Question",
"name": "Peut-on confondre la fièvre jaune avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la dengue ou le paludisme en raison de symptômes similaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes initiaux de la fièvre jaune ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes initiaux incluent fièvre, frissons, douleurs musculaires et céphalées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la fièvre jaune ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires, nausées, et jaunisse."
}
},
{
"@type": "Question",
"name": "La fièvre jaune cause-t-elle des saignements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements peuvent survenir, notamment des saignements gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une forme sévère ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une jaunisse, des douleurs abdominales et des saignements sont des signes de gravité."
}
},
{
"@type": "Question",
"name": "Combien de temps durent les symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent durer de quelques jours à deux semaines, selon la gravité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants présentent des symptômes similaires, mais peuvent avoir des manifestations plus sévères."
}
},
{
"@type": "Question",
"name": "Comment prévenir la fièvre jaune ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est la méthode la plus efficace pour prévenir la fièvre jaune."
}
},
{
"@type": "Question",
"name": "Qui doit se faire vacciner contre la fièvre jaune ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les voyageurs vers des zones à risque et les personnes vivant dans ces zones doivent se vacciner."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires du vaccin ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fièvre légère, douleurs au site d'injection, et fatigue."
}
},
{
"@type": "Question",
"name": "Comment éviter les piqûres de moustiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des répulsifs, portez des vêtements longs et installez des moustiquaires."
}
},
{
"@type": "Question",
"name": "Le vaccin est-il efficace immédiatement ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vaccin confère une protection après 10 jours, mais l'immunité dure plusieurs années."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de la fièvre jaune ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment gérer la déshydratation due à la fièvre jaune ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation par voie intraveineuse est essentielle pour traiter la déshydratation."
}
},
{
"@type": "Question",
"name": "Des médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et antipyrétiques peuvent être utilisés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "La transfusion sanguine est-elle nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une transfusion peut être nécessaire en cas de saignements sévères ou d'anémie."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des antibiotiques pour la fièvre jaune ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les virus, y compris le virus de la fièvre jaune."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la fièvre jaune ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance hépatique, les saignements et le choc."
}
},
{
"@type": "Question",
"name": "La fièvre jaune peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre jaune peut être mortelle, surtout sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies préexistantes et l'absence de vaccination augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'insuffisance hépatique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une jaunisse, des douleurs abdominales et des troubles de la coagulation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des séquelles après la fièvre jaune ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent avoir des séquelles hépatiques ou neurologiques après la maladie."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de contracter la fièvre jaune ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant ou voyageant dans des zones endémiques sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils se préoccuper de la fièvre jaune ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des régions à risque doivent être vaccinés et informés."
}
},
{
"@type": "Question",
"name": "Les personnes non vaccinées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'absence de vaccination augmente considérablement le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent être plus vulnérables aux complications graves de la fièvre jaune."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de complications sévères liées à la fièvre jaune."
}
}
]
}
]
}
Evidence suggests that the implementation of respectful maternity care (RMC) interventions is one of the surest and most effective means of minimising mistreatment during intrapartum care services. Ho...
The study adopted an exploratory descriptive qualitative study design. We conducted nine interviews with charge midwives. All audio data were transcribed verbatim and exported to NVivo-12 for data man...
The study revealed that charge midwives are aware of RMC. Specifically, ward-in-charges perceived RMC as consisting of showing dignity, respect, and privacy, as well as providing women-centred care. O...
We conclude that charge midwives have an important role to play in promoting RMC, which transcends simply providing maternity care. Policymakers and healthcare managers should ensure that charge midwi...
An outbreak involving an extensively antibiotic-resistant Acinetobacter baumannii strain in three military treatment facilities was identified. Fifty-nine isolates recovered from 30 patients over a 4-...
Metal-organic frameworks (MOFs) exhibited huge application potential in electrochemical analysis field, how to facilely and effectively boost the electrochemical sensing activity of MOFs materials sti...
Previous studies have shown that socioeconomic factors play an important role in multiple myeloma (MM) health outcomes. We postulated that the type of treatment facilities and their volume of cases al...
Guidelines for clinical practice have been part of the Ministry of health's efforts to improve the quality of care for over two decades. Their benefits have been documented in Uganda. However, having ...
An exploratory descriptive qualitative study was conducted in three districts in Uganda from September 2020 to January 2021. In-depth interviews with 50 midwives from 35 health centers and 2 hospitals...
Three themes emerged; awareness and use of the guidelines, perceived drivers, and perceived barriers to the provision of immediate postpartum care. The subthemes for theme I included; awareness of the...
The midwives felt that the guidelines were good for the prevention of postpartum complications but their knowledge of the guidelines for the provision of immediate postpartum care was suboptimal. They...
There is a paucity of high-quality evidence on the effectiveness and safety of salt reduction strategies, particularly for older people, who have the most to benefit but are at higher risk of adverse ...
The considerable success of Bangladesh's family planning programs Slowed in recent years due to the low utilization of long-acting reversible contraceptives (LARCs) and permanent methods (PMs). The lo...
To identify disparities in access to NAT for PDAC at the prehospital and intrahospital phases of care....
Delivery of NAT in PDAC is susceptible to disparities in access. There are limited data that accurately locate the etiology of disparities at the prehospital and intrahospital phases of care....
Retrospective cohort of patients ≥18 years old with clinical stage I-II PDAC from the 2010-2016 National Cancer Database. Multiple logistic regression was used to assess 2 sequential outcomes: (1) acc...
A total of 36,208 patients were included for analysis in the prehospital phase of care. Higher education, longer travel distances, being treated at academic/research or integrated network cancer progr...
Non-Black racial minorities and Hispanic patients were less likely to receive NAT at NAT facilities compared to White and non-Hispanic patients, respectively. Discrepancies in administration of NAT wh...
In 2020-2021, a Colorado corrections facility experienced four COVID-19 outbreaks. Case counts, attack rates (ARs) in people who are detained or incarcerated (PDI), and mitigation measures used in eac...
Tuberculosis (TB) remains a major global health challenge, killing millions of people, despite the availability of preventive TB medication. The majority of these infections and deaths occur in low-in...
The PRISMA framework was adopted to identify studies that report on the evidence and barriers and facilitators of administrative, environmental and respiratory control measures at healthcare settings ...
Our review of the 15 included studies identified a cough officer screening system, isolation of TB patients, modification of consultation rooms, and opening windows and doors as effective TB preventio...
Our review provides consistent evidence of TBIC measures in reducing TB transmission in resource-constrained primary healthcare settings. This review has demonstrated that TB transmission can be succe...